Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bilastine vs Cetirizine in Seasonal Allergic Rhinitis
NCT00504933Phase 3Completed
- Sponsor
- Faes Farma
- Start
- May 2005
- Primary completion
- Nov 2005
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of bilastine in seasonal allergic rhinitis (SAR), sponsored by Faes Farma. Started May 2005; status: completed.
02
Drugs
bilastine
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00504933.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00504933.